Adam Lohr is an assurance partner and senior analyst in the life sciences industry for RSM US LLP, based in the firm’s San Diego office. He was selected as a senior analyst in RSM’s Industry Eminence Program, which positions its senior analysts to understand, forecast, and communicate economic, business, and technology trends shaping the life sciences industry.
As part of the firm’s Industry Eminence Program, Adam works with high-growth private equity and venture capital-backed startup organizations in the biopharma and biotech industries, as well as commercialized medical technology companies. He is particularly passionate about assisting under-resourced, idea-rich biotech startups that populate the life sciences arena.
His consultative approach leverages the power of understanding a client’s goals and applying the appropriate solutions and methodologies for success. Adam works closely with the firm’s chief economist to better understand how economic factors, changing societal influences and technology affect a client’s business. He helps scientists run the business operations of their labs by addressing the macroeconomic trends within labor, supply chains, capital markets and emerging technologies that may affect their businesses.
A people person and team builder, Adam has strong relationships with both clients and colleagues. With the current complexity of the economy, he understands that leveraging the strength of high-performing teams is the path to success.
He has held many leadership roles within the firm, including West region industry leader for life sciences. He is also a member of the firm’s national life sciences team and was recently selected for the firm’s next generation enterprise account leadership program. He participates in several of the firm’s employee network groups.
